Abstract

Breast cancer is the second leading cause of cancer-related mortality among women globally with obesity being one risk factor. Obese breast cancer patients have at least a 30% increased risk of death from breast cancer compared to non-obese breast cancer patients because they present with larger tumors and generally have increased rates of metastasis. Moreover, obese breast cancer patients respond more poorly to treatment compared to non-obese patients, particularly pre-menopausal women diagnosed with triple negative breast cancer (TNBC). To help understand the molecular mechanisms underlying the increased metastasis associated with obesity, we previously established a three-dimensional culture system that permits the co-culture of adipocytes and TNBC cells in a manner that mimics an in vivo milieu. Using this system, we demonstrate that white adipose tissue from both lean and obese mice can induce a partial mesenchymal-to-epithelial transition (MET). Triple negative breast cancer cells adopt an epithelial morphology and have an increased expression of some epithelial markers, but they maintain the expression of mesenchymal markers, furnishing the breast cancer cells with hybrid properties that are associated with more aggressive tumors. Thus, these data suggest that adipose tissue has the potential to promote secondary tumor formation in lean and obese women. Further work is needed to determine if targeting the partial MET induced by adipose tissue could reduce metastasis.

Highlights

  • Breast cancer (BC) is one of the most prevalent and deadliest cancers among women [1]

  • Our findings show that conditioned media (CM) from both lean and obese mice white adipose tissue (WAT) can induce a mesenchymal-to-epithelial transition (MET)-like change in mesenchymal MDA-MB-231 triple negative breast cancer (TNBC) cell line

  • To assess the effect of mouse WAT on the colony morphology of mesenchymal TNBC cells grown in 3D, 400 mg of peri-uterine and inguinal WAT were isolated from lean

Read more

Summary

Introduction

Breast cancer (BC) is one of the most prevalent and deadliest cancers among women [1]. Women who are obese have a 30% increased risk of death from BC compared to non-obese women due to larger tumor sizes and increased rates of metastasis [1,3,4,5]. Post-menopausal obese women are at an increased risk of death from estrogen receptor or progesterone receptor-positive BC, while obese pre-menopausal women are most likely to die from triple negative breast cancer (TNBC) [6]. Obese BC patients respond more poorly to treatment compared to non-obese patients, especially those with TNBC [6,7]. The reasons behind the poor treatment outcome are not fully understood; obesity is associated with the systemic elevation of insulin-like growth factor 1 (IGF-1), adipokines, cytokines, and pro-angiogenic factors, which create a pro-oncogenic environment [8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call